Harry L. Leider - Dec 19, 2023 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Executive Officer, Director
Signature
/s/ Harry L. Leider
Stock symbol
OCEL
Transactions as of
Dec 19, 2023
Transactions value $
-$6,901
Form type
4
Date filed
12/20/2023, 04:05 PM
Previous filing
Jun 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale -$6.9K -5.25K -100% $1.32 0 Dec 19, 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares disposed of were held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.